About Thomas
Thomas has over 20 years of experience representing industry leaders in life sciences. He is internationally recognized for his experience in creating, implementing and monetizing effective patent strategies. He represents public and private companies, investors and academic institutions in the life sciences arena. His portfolio of life sciences companies spans diagnostics, medical devices, life science tools and technology platforms, genomics and therapeutics.Before joining Sullivan, Tom was a partner at several global law firms in Boston. Previously, Tom served as Vice President and General Counsel of Helicos BioSciences Corporation, where he directed and implemented patent and legal strategies and played a significant role in that company’s IPO.Tom speaks and writes extensively on patent and licensing matters, and presents frequently at major pharma and life sciences meetings. Tom is a leader in creating monetized barriers to entry, and he is responsible for creating the foundational IP for a number of successful life sciences companies. Tom has served as an adjunct professor of law at Suffolk University Law School and most recently at MIT. He is also recognized in the 2025 edition of Best Lawyers® for Patent Law.
Thomas has over 20 years of experience representing industry leaders in life sciences. He is internationally recognized for his experience in creating, implementing and monetizing effective patent strategies. He represents public and private companies, investors and academic institutions in the life sciences arena. His portfolio of life sciences companies spans diagnostics, medical devices, life science tools and technology platforms, genomics and therapeutics.Before joining Sullivan, Tom was a partner at several global law firms in Boston. Previously, Tom served as Vice President and General Counsel of Helicos BioSciences Corporation, where he directed and implemented patent and legal strategies and played a significant role in that company’s IPO.Tom speaks and writes extensively on patent and licensing matters, and presents frequently at major pharma and life sciences meetings. Tom is a leader in creating monetized barriers to entry, and he is responsible for creating the foundational IP for a number of successful life sciences companies. Tom has served as an adjunct professor of law at Suffolk University Law School and most recently at MIT. He is also recognized in the 2025 edition of Best Lawyers® for Patent Law.
Thomas has over 20 years of experience representing industry leaders in life sciences. He is internationally recognized for his experience in creating, implementing and monetizing effective patent strategies. He represents public and private companies, investors and academic institutions in the life sciences arena. His portfolio of life sciences companies spans diagnostics, medical devices, life science tools and technology platforms, genomics and therapeutics.
Before joining Sullivan, Tom was a partner at several global law firms in Boston. Previously, Tom served as Vice President and General Counsel of Helicos BioSciences Corporation, where he directed and implemented patent and legal strategies and played a significant role in that company’s IPO.
Tom speaks and writes extensively on patent and licensing matters, and presents frequently at major pharma and life sciences meetings. Tom is a leader in creating monetized barriers to entry, and he is responsible for creating the foundational IP for a number of successful life sciences companies. Tom has served as an adjunct professor of law at Suffolk University Law School and most recently at MIT. He is also recognized in the 2025 edition of Best Lawyers® for Patent Law.
